This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Alnylam Pharmaceuticals Inc (ALNY)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 75.18M 53.17M 51.40M 70.23M
Receivables 39.94M 4.25M 104.00K 1.47M
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 746.37M 254.03M 125.46M 152.03M
Property, Plant & Equipment, Gross 67.83M 57.76M 55.27M 45.57M
Accumulated Depreciation & Depletion 46.09M 41.32M 35.47M 30.92M
Property, Plant & Equipment, Net 21.74M 16.45M 19.80M 14.64M
Intangibles 0.00 0.00 0.00 275.00K
Other Non-Current Assets 279.82M 150.05M 142.26M 114.97M
Total Non-Current Assets 333.23M 166.50M 162.06M 129.89M
Liabilities & Shareholder Equity
Total Assets 1.08B 420.53M 287.52M 281.92M
Accounts Payable 15.11M 5.90M 4.42M 5.80M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 1.00M 1.11M 0.00 484.00K
Total Current Liabilities 95.33M 53.86M 48.34M 80.99M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 5.01M 2.92M 0.00 3.73M
Other Non-Current Liabilities 42.98M 93.39M 105.12M 79.20M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 47.99M 96.32M 105.12M 82.93M
Total Liabilities 143.33M 150.18M 153.47M 163.92M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 936.27M 270.35M 134.05M 118.00M
Common Par 772.00K 637.00K 525.00K 427.00K
Additional Paid In Capital 1.84B 846.23M 624.88M 518.73M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -956.63M -596.24M -507.01M -401.00M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 48.76M 19.72M 15.66M -165.00K
Total Capitalization 936.27M 270.35M 134.05M 118.00M
Total Equity 936.27M 270.35M 134.05M 118.00M
Total Liabilities & Stock Equity 1.08B 420.53M 287.52M 281.92M
Total Common Shares Outstanding 77.20M 63.74M 52.49M 42.72M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 74.28M 61.55M 50.29M 42.41M
Diluted Weighted Shares Outstanding 74.28M 61.55M 50.29M 42.41M
Number of Employees 256 165 129 116
Number of Part-Time Employees 0 0 0 0

ALNY Alnylam Pharmaceuticals Inc

Analysts Ratings for ALNY

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 7 4 4 4
Moderate Buy 1 1 1 1
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

ALNY Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs